12/8/08 GeoVax Labs and VGX International Announce Agreement at the Las Vegas “International Society of DNA Vaccines” Conference
10/24/08 VGX International signs a Master Product Sale Agreement with BioCancell Therapeutics of Israel to supply plasmid for its multiple clinical programs
7/3/08 Senesco Chooses VGXI To Produce Factor 5A Plasmid
5/19/08 VGX announces filings of two separate INDs covering novel DNA vaccines: one for cervical cancer therapy (VGX-3100) and one for avian influenza (VGX-3400)
5/12/08 VGX signs multi-year production agreement with the United Kingdom Cystic Fibrosis Gene Therapy Consortium
2/8/08 VGX announces the IND filing of VGX-3200, a novel DNA therapy that utilizes GHRH for the treatment of cancer cachexia and anemia
2/5/08 VGX announces Initiation of VGX-cGMP Manufactured Plasmid Products in Clinical Use by Partners
1/9/08 VGX Animal Health announces approval of LifeTide™ SW 5 - World’s First and Only Approved DNA Therapy for Food Animals
10/29/07 VGX announces an agreement with VGX International to build a large scale cGMP DNA manufacturing plant in Korea
10/24/07 VGX adds cGMP plasmid DNA manufacturing capacity
7/11/07 VGX Announces Issuance of Two Key U.S. Patents Covering DNA Plasmid Manufacturing Technology and the Treatment of Anemia

 


 

 
© 2008 VGXI Inc. All rights reserved.